Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Drops By 79.3%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 3,500 shares, a decrease of 79.3% from the May 31st total of 16,900 shares. Based on an average daily trading volume, of 56,600 shares, the days-to-cover ratio is presently 0.1 days.

BriaCell Therapeutics Price Performance

BCTXW stock traded up $0.00 during midday trading on Friday, hitting $0.27. The stock had a trading volume of 74,052 shares, compared to its average volume of 37,475. The business has a fifty day moving average price of $0.60 and a two-hundred day moving average price of $1.26. BriaCell Therapeutics has a 1-year low of $0.17 and a 1-year high of $3.30.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.